Skip to main content

This site is intended for healthcare professionals outside of the United States (US) and the United Kingdom (UK).

This site is created and funded by Novartis.

If you are an HCP from one of the countries listed, you may select your country from the list to be redirected to your specific site.

Change country or language (Non-US)
  • International
  • https://rltcare.novartis.com/
    Global
  • https://rltcare.novartis.com/de-de/
    Germany
  • https://rltcare.novartis.com/es-es/
    Spain
  • https://www.rltcare.novartis.com/fr-fr/
    France
  • https://www.rltcare.novartis.com/pt-pt/
    Portugal
  • https://www.rltcare.novartis.com/br-pt/
    Brazil
  • https://www.rltcare.novartis.com/jp-ja/
    Japan
Learn from experts to prepare your center

PSMA-PET/CT Imaging

In this video, Prof Fendler discusses the indications for a PSMA-PET/CT scan in prostate cancer, the initial preparation required by staff including patient education, consent, hydration and the use of furosemide to reduce bladder uptake. He also covers the types of radiotracers, the administration protocols, and the importance of accurate interpretation of PSMA-PET/CT scan images to avoid false positives. Additionally, he highlights the need for proper imaging techniques and the potential pitfalls in interpreting PSMA-PET/CT scans.

Video Url

Get in touch

Our dedicated RLT specialist teams aim to streamline care coordination and alleviate uncertainty, ensuring you and your patients feel confident and supported every step of the way.